Actions
L'actualité boursière de la SIX et du SMI, du DAX et de l'ATX et des actions européennes, avec les mouvements mondiaux qui les animent.
Holcim Shares Extend Decline Despite Stronger 2026 Outlook and Earnings
The Swiss building materials group's stock fell 3.5 percent over the week, mirroring broader sector weakness driven by energy costs and high interest rates.
Zurich Insurance Shares Face Declines Amid Broader Market Pressures
Zurich Insurance shares head toward a fifth consecutive daily loss, reflecting a wider downturn across Swiss and global financial equities.
Julius Baer Launches CHF 600 Million Share Buyback and Updates Capital Policy
The Swiss wealth management group announced a share buyback program of up to CHF 600 million alongside a revised capital distribution policy targeting a CET1 ratio of 15%.
Frankfurt Stocks Close: DAX Slips Below 25,000 Points as 200-Day Moving Average Holds
The German DAX fell 1.03% to close below 25,000 points on Thursday, finding temporary support at its 200-day moving average amid pressure from high oil prices, rising bond yields, and weak US markets.
DAX Closes Lower as Inflation Concerns Offset Positive US Data
Germany's DAX index dropped 0.79 percent on Wednesday, finishing a weak September in negative territory as persistent domestic inflation overshadowed favorable US economic reports.
JPMorgan Buys Into Struggling Swiss Biotech Kuros Despite 34% Year-to-Date Slide
Wall Street giant expands stake to over 5% in Kuros Biosciences as stock trails 2024's top Swiss performer. UBS also flags Swiss names among its top European tactical picks.
BMW Unveils Major Restructuring, Targets 8-10% ROE by Early 2030s
BMW announced a broad corporate overhaul on Wednesday, including 8,000 job cuts in Munich and a localized product strategy, aiming to restore profitability after a tough period.
EuroStoxx 50 climbs 0.3% as investors stay upbeat amid oil and bond yields
The EuroStoxx 50 rose to 6,320.26 points, led by a 4.2% gain in ASML, while Swiss and UK benchmarks showed mixed moves. Analysts cite optimism on Middle‑East de‑escalation and tech growth.
DocMorris shares rise 10% as target raised, Redcare lagging
DocMorris stock has doubled year‑to‑date after a 10% jump, with Research Partners lifting its price target to CHF 14.60. Analyst compares it with slower‑gaining rival Redcare Pharmacy.
DAX slips 0.13% to 25,374 as US weakness drags German shares
The German DAX closed at 25,374.42 points, down 0.13%, after late‑day losses tied to weak US markets, rising oil and gold prices and concerns over AI sector funding.
Calida lifts dividend and launches 2% share buyback, but analysts stay cautious
Swiss apparel group Calida announced a dividend payout increase to 40‑60% of adjusted earnings and a share repurchase of up to 2% of capital. Analysts say the moves improve returns but urge faster brand investment.
Roche's Pharma Day Targets Fail to Win Over Investors
The Swiss drugmaker unveiled ambitious R&D goals and cost-cutting plans, but shares slipped as investors remained unimpressed with the outlook.
European stocks stay flat as Iran tensions lift oil, bond yields and hit tech shares
The Swiss Market Index edged up 0.06% while the DAX and EuroStoxx50 were unchanged; Brent rose to $108 and 10‑year German yields hit 3.65% amid geopolitical risk and AI concerns.
Helvetia Introduces VivaFlex for Flexible Private Pensioning
Swiss insurer Helvetia launches VivaFlex, a new life insurance product designed to adapt to evolving life stages, including part-time work and career transitions.
Roche pushes aggressive pipeline expansion at Pharma Day, cites AI and new "Bar" criteria
Roche outlined a goal of up to 20 new drugs by 2030, introduced a stricter "Bar" framework for candidate selection and highlighted artificial‑intelligence integration across research, aiming for >30 bn CHF sales from top prospects.
Bernstein Names Sonova, Alcon Top European Medtech Picks for H2
The firm highlighted Sonova as its short-term top pick and Alcon as the preferred long-term play, citing strong fundamentals in hearing aids and ophthalmology.
SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms
Swiss stock market shows slight gains; UBS and Givaudan see increased interest; semiconductor stocks rise; Nestlé underperforms; new ratings and price targets for Swiss stocks
SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles
Swiss stock market shows resilience, with ABB and UBS gaining while Nestlé lags. Oil prices and bond yields remain key market drivers.
SMI climbs as ABB and UBS gain; oil prices fall
Swiss stock market rises, with ABB and UBS among top gainers, while oil prices decline. Analysts warn of rising bond yields.
Swiss Stocks Set for Higher Open on Upgrades, SNB Holds Rates
The SMI looks to open 0.4% higher as UBS upgrades Glencore and analysts revise targets on Swiss shares; the SNB keeps rates at zero percent while oil prices ease.
US equities retreat as S&P 500 slips 0.75%
Treasury yields rise, dollar strengthens amid global bond selloff and elevated inflation risks.
US Futures Slip; Oil Bounces, SMI Erases Gains, Nvidia Pre-Market Down
Wall Street opens lower as oil stabilizes and geopolitical hopes offset by chip-sector pullback; SMI surrenders morning gains ahead of SNB decision.
European markets hold steady amid oil price focus
Indices show modest gains, with tech and retail sectors leading, while KI-driven valuations face scrutiny
Swiss Market Holds Steady Amid Mixed US Openings; UBS Regulatory Loss Weighs on Blue Chips
The Swiss Market Index (SMI) held near break-even, while UBS faced losses after a Ständerat ruling on stricter capital requirements. US markets opened mixed, with Nasdaq futures unchanged but Dow Jones and S&P 500 futures rising slightly.